Table of Contents
Editorial
| Cardiovascular benefits and risk profiles of oral anti-diabetic agents: current evidence and ongoing trials | PDF HTML |
| Yi-Cheng Chang, Juey-Jen Hwang, Shih-Che Hua | 386-392 |
| The Role of Cardiac Biomarkers in Predicting of Mortality in Diabetic Patients | PDF HTML |
| Alexander E. Berezin | 400-404 |
Review
| Statins and Heart Failure | PDF HTML |
| Juan J. Chillarón, David Benaiges, Elisenda Climent, Juana A. Flores-Le Roux, Juan Pedro-Botet | 405-409 |
| Electrocardiographic Features in the Diagnosis and Risk Assessment of Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia | PDF HTML |
| Stefan Stefan Peters | 141-417 |
| 2015 Guidelines on Treatment of Hypertension in Patients With Coronary Artery Disease | PDF HTML |
| Wilbert S. Aronow | 418-421 |
| New Clinical Trials With Evolocumab and Alirocumab on Cardiovascular Outcomes, in Patients With High Rsk of Acute Coronary Syndromes | PDF HTML |
| Singh RB, Krasimira Hristova, Jan Fedacko, Galal Elkilany, Narsingh Verma | 422-424 |
| Can Prevention of Low Birth Weight in Newborn may be Associated with Primordial Prevention of Cardiovascular Diseases and Type 2 Diabetes in Adult Life? | PDF HTML |
| RB Singh, Banshi Saboo, Anuj Maheshwari, Poonam Singh, NS Verma, Shantanu Singhal, Zubin Pradeep Sharma | 425-429 |
Original Article
| Clinical Outcomes of Pharmaco-invasive ST-elevation Myocardial Infarction Management in a Large Australian Regional Centre | PDF HTML |
| Bo Xu, Voltaire Nadurata, Kate Avery, Charles Chilvers, Shelene Laiu | 430-435 |
This work is licensed under a Creative Commons Attribution 3.0 License.
ISSN: 2312-122X
